Joint Formulary & PAD

Pizotifen - Migraine (prevention)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Documents :
 

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Pizotifen
Indication :
Migraine (prevention)
Group Name :
Keywords :
cluster headaches, migraine prevention, migraine prophylaxis
Brand Names Include :
Sanomigran
Important Information :
Review existing patients and consider alternative. Discontinuation of pizotifen requires gradual withdrawal.
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
1

Other Indications

Below are listed other indications that Pizotifen is used to treat.

  • No records returned.

Committee Recommendations (2)

The Medicine Safety Committee has developed "Pizotifen safety advice" for healthcare professionals to consider when prescribing and monitoring patients on pizotifen

This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status